Evidence map›Paper›PMID 41933729›Full record

ArticleThe Journal of biological chemistry2026

"Molecular insights into the bactericidal toxin Tle1 of Pseudomonas aeruginosa: Interaction with VgrG, its adaptor, and its immunity protein".

Delphine Lefebvre, Chantal Soscia, Laura Schmitt, Adeline Goulet, Bérengère Ize, Sophie Bleves

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Delphine LefebvreLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France.
Chantal SosciaLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France.
Laura SchmittLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France.
Adeline GouletLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France.
Bérengère IzeLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France.
Sophie BlevesLaboratoire d'Ingénierie des Systèmes Macromoléculaires (LISM), UMR7255, Aix-Marseille Université, CNRS, Marseille, France. Electronic address: bleves@imm.cnrs.fr.

Funding

ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
NIGMS NIH HHS R01 GM129325
6 · The paper itself

Abstract

The Type VI secretion system delivers a wide range of antibacterial effectors, including phospholipases of the Tle family. Here, we characterize Tle1 from Pseudomonas aeruginosa and demonstrate that it functions as a bactericidal toxin when associated to the membranes in the periplasm. Bacterial two-hybrid assays revealed specific protein-protein interactions within the tle1 locus, involving the immunity protein Tli1a, the chaperone/adapter Tla1, and the spike protein VgrG4a. These interactions were independently validated by co-purification assays. Structural modeling with AlphaFold 3 produced a high-confidence ternary complex in which a VgrG4a trimer accommodates one Tle1 monomer and one Tla1 monomer. The three predicted interfaces (Tle1-Tla1, Tla1-VgrG4a, and Tle1-VgrG4a) were confirmed experimentally in vivo and important charged residues mediating these interfaces were identified. Furthermore, modeling of the Tle1-Tli1a complex suggests an inhibition mechanism that does not occlude the catalytic pocket. Consistently, Tli1a was localized to the outer membrane of P. aeruginosa, supporting in silico predictions of an outer membrane lipoprotein and positioning it ideally to neutralize periplasmic Tle1 activity. In contrast, we did not detect the second candidate immunity protein, Tli1b, either in P. aeruginosa or in Escherichia coli, and, following a bioinformatic analysis of the locus of the PAO1 strain, we propose that it is a pseudogene. Together, these findings elucidate the molecular interactions underlying Tle1 delivery and inhibition and highlight the role of Tli1a as a dedicated immunity protein that protects P. aeruginosa from self-intoxication.

Indexed as

Bacterial ProteinsBacterial ToxinsPseudomonas aeruginosaModels, MolecularBacterial ProteinsBacterial Toxinsalphafoldantibacterial toxinbacterial pathogenesisDUF4123 adapterimmunity proteinprotein secretionPseudomonas aeruginosastructure/function analysisTle1 phospholipasetype VI secretion system (T6SS)VgrG

Identifiers

PMID41933729
PMCPMC13133936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.